4,543 results on '"Eckman, C."'
Search Results
2. Metabolism and Function of Presenilin 1
3. Presenilins and Alzheimer’s disease: the role of Aβ42
4. Perspectives on Deterrents from Students Who Have Discontinued Prescription Stimulant Misuse and Diversion Behaviors.
5. Neuropathologic and stereological assessment of dopaminergic and non-dopaminergic neurons in the brains of dystonia patients: Focus on substantia nigra: 1376
6. Amyloid β and impairment in multiple memory systems in older transgenic APP TgCRND8 mice
7. ENZYME REPLACEMENT THERAPY FOR GLOBOID CELL LEUKODYSTROPHY: C08–01
8. Metabolism and Function of Presenilin 1
9. Reduction of Aβ accumulation in the Tg2576 animal model of Alzheimer’s disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin1
10. TRANSGENIC MICE OVEREXPRESSING HUMAN PRESENILIN-1
11. METABOLISM AND FUNCTION OF PRESENILIN 1.
12. Using Drosophila amyloid toxicity models to study Alzheimer's disease.
13. Experimental Demonstration of a Soft X-Ray Self-Seeded Free-Electron Laser
14. Preterm Prelabor Rupture of Membranes: Outcomes with Expectant Management until 34 versus 35 Weeks.
15. Exploring the Potential Therapeutic Approach Using Ginsenosides for the Management of Neurodegenerative Disorders.
16. Role of PIM Kinase Inhibitor in the Treatment of Alzheimer's Disease.
17. Amyloid, PHF-tau, Ubiquitin and Synaptic Markers in the Progression of Alzheimer's Disease: Immunochemical Analyses of Frontal Cortex from Prospectively Studied Elderly Humans
18. Molecular Characterization of Mutations That Cause Globoid Cell Leukodystrophy and Pharmacological Rescue Using Small Molecule Chemical Chaperones
19. The Secreted -Amyloid Precursor Protein Ectodomain APPs Is Sufficient to Rescue the Anatomical, Behavioral, and Electrophysiological Abnormalities of APP-Deficient Mice
20. 2.439 Neuronal recovery in a rodent model of PD following environmental enrichment
21. No major effect of dopamine receptor 1/5 antagonist SCH-23390 on epileptic activity in the Tg2576 mouse model of amyloidosis.
22. Dopamine D3 Receptor Agonist Delivery to a Model of Parkinson's Disease Restores the Nigrostriatal Pathway and Improves Locomotor Behavior
23. Physiologic and Pathologic Events Mediated by Intramembranous and Juxtamembranous Proteolysis
24. Amyloid, PHF-tau, Ubiquitin and Synaptic Markers in the Progression of Alzheimer's Disease: Immunochemical Analyses of Frontal Cortex from Prospectively Studied Elderly Humans.
25. A New Pathogenic Mutation in the APP Gene (I716V) Increases the Relative Proportion of A 42(43)
26. Genetic Modification of the Phenotypes Produced by Amyloid Precursor Protein Overexpression in Transgenic Mice
27. Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
28. The effect of amyloid precursor protein and presenilin mutations on amyloid beta protein
29. 149 The Presenilin 1 and 2 mutations linked to familial Alzheimer's Disease increase the extracellular concentration of amyloid 0 protein (Aβ) ending at Aβ42(43)
30. Critical thinking of Alzheimer's transgenic mouse model: current research and future perspective.
31. β-Amyloids and Immune Responses Associated with Alzheimer's Disease.
32. Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer’s disease mutations.
33. Lost in translation: Inconvenient truths on the utility of mouse models in Alzheimer's disease research.
34. 幽门螺杆菌在阿尔兹海默症发生发展中的 作用机制研究进展.
35. Gene-variant specific effects of plasma amyloid-β levels in Swedish autosomal dominant Alzheimer disease.
36. Bioavailability as Proof to Authorize the Clinical Testing of Neurodegenerative Drugs—Protocols and Advice for the FDA to Meet the ALS Act Vision.
37. Pathological Involvement of Protein Phase Separation and Aggregation in Neurodegenerative Diseases.
38. Resilience to structural and molecular changes in excitatory synapses in the hippocampus contributes to cognitive function recovery in Tg2576 mice.
39. Chronic administration of prebiotics and probiotics ameliorates pathophysiological hallmarks of Alzheimer's disease in a APP/PS1 transgenic mouse model.
40. "Prion-like" seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders.
41. Sex and Gender Differences in Alzheimer's Disease: Genetic, Hormonal, and Inflammation Impacts.
42. Amyloid-independent pathogenesis for Alzheimer's disease: implications for drug design.
43. PSEN2 Mutations May Mimic Frontotemporal Dementia: Two New Case Reports and a Review.
44. Exploring the complexity of amyloid-beta fibrils: structural polymorphisms and molecular interactions.
45. Determination of Spinal Cord Monamines and Metabolites Using Three Micron Columns and Dual Electrochemical Detection.
46. Border-associated macrophages promote cerebral amyloid angiopathy and cognitive impairment through vascular oxidative stress.
47. Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme.
48. International information update Acquiring international documents: challenges, strategies, sources
49. High throughput screens for the identification of compounds that alter the accumulation of the Alzheimer's amyloid b peptide (Ab)
50. b-Secretase cleavage of the amyloid precursor protein mediates neuronal apoptosis caused by familial Alzheimer`s disease mutations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.